23 Jul, 2026
According to Straits Research, the global chronic hemodialysis catheter market size was valued at $435.69 million in 2025 and is projected to grow from $451.24 million in 2026 to $597.42 million by 2034, at a CAGR of 3.57% during the forecast period 2026–2034.
Hemodialysis is a blood filtration method for patients with kidney failure. A catheter is used to connect a patient to a dialysis machine in order to perform dialysis. Blood exchange catheter lumens (flexible tubular passages) are colored red and blue for easy identification during the dialysis procedure. The red-colored lumen (atrial lumen) transfers blood from the patient to the dialysis machine for filtration, while the blue-colored lumen (venous lumen) returns blood to the patient after the dialysis machine filtration. A catheter is advanced into the chest by inserting it into one of the large veins, such as the superior vena cava, or by puncturing the internal jugular vein in the neck. The range of blood flow through a catheter is 200 to 500 milliliters per minute. There are cuffed tunneled catheters, non-cuffed tunneled catheters, and non-tunneled catheters available for hemodialysis catheters.
Patients are compelled to use dialysis products and services as the incidence of kidney diseases rises, which drives demand for hemodialysis catheters. Catheters for hemodialysis provide temporary vascular access to correct metabolic imbalances caused by renal dysfunction. Permanent vascular access is recommended for dialysis due to its lower complication rates and greater efficacy; however, the demand for catheters continues to rise due to various patient health factors. Increasing age and comorbid conditions, such as diabetes and vascular disease, can inhibit the formation and maintenance of fistulas and grafts in patients. The delay in referral to a nephrologist for the creation of an arteriovenous fistula (AFV) and the failure of fistulas or grafts are some of the reasons for the continued use of hemodialysis catheters. Consequently, the increase in hemodialysis catheter usage is anticipated to drive the market for chronic hemodialysis catheters over the forecast period.
Home hemodialysis is a hemodialysis technique that can be performed in the home. Home hemodialysis has numerous benefits, including the ability to perform treatment more frequently and for longer periods of time without interruption. There are two types of home hemodialysis treatments: short, daily hemodialysis and traditional, four-hour sessions performed up to three times per week. Home hemodialysis provides patients with greater control over dialysis and improves their quality of life. The cumulative prevalence of in-center hemodialysis is likely to compel hemodialysis patients to switch to home hemodialysis in order to better manage the dialysis process. It is anticipated that the expansion of personalized users will increase hemodialysis catheter sales.
North America held a leading position in the chronic hemodialysis catheter market, accounting for approximately 38.56% of the global share in 2025. This dominance is supported by a large dialysis patient base and advanced healthcare infrastructure. According to the US Renal Data System, over 550,000 patients in the country are undergoing dialysis, with hemodialysis being the primary modality. Data from the Centers for Disease Control and Prevention indicates that nearly 80% of patients initiate hemodialysis using a catheter, highlighting strong dependence on these devices. This high patient volume, combined with structured care delivery and monitoring systems, sustains consistent demand for chronic catheter utilization across the region.
Asia Pacific is emerging as the fastest-growing region in the chronic hemodialysis catheter market with a growth rate of 6.5% during the forecast period, supported by a substantial and rising disease burden. Evidence from PubMed Central indicates that up to 434 million adults in Asia are living with chronic kidney disease, with approximately 65 million in advanced stages requiring intensive care or dialysis. CKD prevalence across the region ranges between 7% and 34%, highlighting significant unmet clinical needs. This large and heterogeneous patient pool, combined with increasing progression to end-stage renal disease, is driving sustained demand for dialysis access solutions, positioning Asia Pacific as a high-growth, volume-driven market for chronic hemodialysis catheters.
sales@straitsresearch.com